These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8259980)

  • 21. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
    Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
    Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New purines with antiplatelet activity.
    Märschenz K; Rehse K
    Arch Pharm (Weinheim); 2006 Mar; 339(3):115-22. PubMed ID: 16493596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype.
    Cano C; Barbeau OR; Bailey C; Cockcroft XL; Curtin NJ; Duggan H; Frigerio M; Golding BT; Hardcastle IR; Hummersone MG; Knights C; Menear KA; Newell DR; Richardson CJ; Smith GC; Spittle B; Griffin RJ
    J Med Chem; 2010 Dec; 53(24):8498-507. PubMed ID: 21080722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiplatelet activity of inositol hexaphosphate (IP6).
    Vucenik I; Podczasy JJ; Shamsuddin AM
    Anticancer Res; 1999; 19(5A):3689-93. PubMed ID: 10625941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Synthesis and reactivity of debenzorutaecarpine derivatives].
    Kökösi J; Almási J; Kiss A; Forgó P; Böcskei Z; Fehér M; Hermecz I
    Acta Pharm Hung; 1999 Jun; 69(3):135-46. PubMed ID: 10401157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.
    Hasegawa M; Sugidachi A; Ogawa T; Isobe T; Jakubowski JA; Asai F
    Thromb Haemost; 2005 Sep; 94(3):593-8. PubMed ID: 16268477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, identification and antiplatelet evaluation of 2-morpholino substituted benzoxazines.
    Pritchard KM; Al-Rawi J; Bradley C
    Eur J Med Chem; 2007 Sep; 42(9):1200-10. PubMed ID: 17336427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as platelet aggregation inhibitors.
    Tian X; Wang LY; Xia S; Li ZB; Liu XH; Yuan Y; Fang L; Zuo H
    Bioorg Med Chem Lett; 2012 Jan; 22(1):204-6. PubMed ID: 22137848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
    Rehse K; Kotthaus J; Khadembashi L
    Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, antiplatelet and antithrombotic activities of new 2-substituted benzopyrano[4,3-d]pyrimidin-4-cycloamines and 4-amino/cycloamino-benzopyrano[4,3-d]pyrimidin-5-ones.
    Bruno O; Brullo C; Schenone S; Bondavalli F; Ranise A; Tognolini M; Impicciatore M; Ballabeni V; Barocelli E
    Bioorg Med Chem; 2006 Jan; 14(1):121-30. PubMed ID: 16154749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
    Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
    Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluation.
    Campillo N; García C; Goya P; Páez JA; Carrasco E; Grau M
    J Med Chem; 1999 May; 42(10):1698-704. PubMed ID: 10346922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human platelet aggregation inhibitors from thyme (Thymus vulgaris L.).
    Okazaki K; Kawazoe K; Takaishi Y
    Phytother Res; 2002 Jun; 16(4):398-9. PubMed ID: 12112303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Synthesis and platelet aggregation inhibitory activity of 6-substituted dihydropyridazinones].
    Yao FM; Sun CS
    Yao Xue Xue Bao; 1993; 28(7):548-52. PubMed ID: 8285059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure Activity Relationship of 4-Amino-2-thiopyrimidine Derivatives as Platelet Aggregation Inhibitors.
    Cacciari B; Crepaldi P; Cheng CY; Bossi E; Spalluto G; Federico S; Jacobson KA; Cattaneo M
    Med Chem; 2019; 15(8):863-872. PubMed ID: 30734681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyrimidines. Part II: Synthesis of novel pyrimidines, 1,2,4-triazolo[4,3-a]pyrimidin-7-ones and pyrimidino[2,1-c][1,2,4]triazin-8-ones for their antimicrobial and anticancer activities.
    Habib NS; Soliman R; Ismail K; Hassan AM; Sarg MT
    Boll Chim Farm; 2003 Nov; 142(9):396-405. PubMed ID: 14971308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of isoquinoline alkaloids of different structural types on antiplatelet aggregation in vitro.
    Chia YC; Chang FR; Wu CC; Teng CM; Chen KS; Wu YC
    Planta Med; 2006 Oct; 72(13):1238-41. PubMed ID: 16981134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.